Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks Inc., recently posted on X:
“It was such an honor and a pleasure to open the DAVA Oncology Think Tank on Antibody Drug Conjugates and Bispecifics meeting in Victoria!
Thank you, Vinay and the organizers for a fantastic two days of interactions between clinicians and ADC developers!”
Source: Raffaele Colombo/X
